Potassium metal batteries are considered as attractive alternatives beyond lithium-ion batteries. However, the uncontrollable dendrite growth on the potassium metal anode has restrained their practical applications. Herein, we report a high-performance potassium anode achieved by confining potassium metal into a titanium-deficient nitrogen-containing MXene/carbon nanotube free-standing scaffold. The high electronic transport and fast potassium diffusion in this scaffold enable reduced local current density and homogeneous ionic flux during plating/stripping process. Furthermore, as verified by theoretical calculations and experimental investigations, such "potassium-philic" MXene sheets can induce the nucleation of potassium, and guide potassium to uniformly distribute in the scaffold upon cycling. Consequently, the as-developed potassium metal anodes exhibit a dendrite-free morphology with high Coulombic efficiency and long cycle life during plating/stripping process. Such anodes also deliver significantly improved electrochemical performances in potassium-sulfur batteries compared with bare potassium metal anodes. This work can provide a new avenue for developing potassium metal-based batteries. Received: ((will be filled in by the editorial staff)) Revised: ((will be filled in by the editorial staff))
HIGHLIGHTSNovel synthesis of aerogel-like porous MXene architectures Porous MXene architectures can effectively prevent the restack of MXene nanosheets Porous MXene demonstrated a high electroadsorption capacity MXene electrodes achieved a high capacitive deionization capacity
Non-technical summary Wasting and severely impaired function of skeletal muscle is frequently observed in critically ill intensive care unit (ICU) patients, with negative consequences for recovery and quality of life. An experimental rat ICU model has been used to study the mechanisms underlying this unique wasting condition in neuromuscularly blocked and mechanically ventilated animals at durations varying between 6 h and 2 weeks. The complete 'mechanical silencing' of skeletal muscle (removal of both weight bearing and activation) resulted in a specific myopathy frequently observed in ICU patients and characterized by a preferential loss of the motor protein myosin. A highly complex and coordinated protein synthesis and degradation system was observed in the time-resolved analyses. It is suggested the 'mechanical silencing' of skeletal muscle is a dominating factor triggering the specific myopathy associated with the ICU intervention, and strongly supporting the importance of interventions counteracting the complete unloading in ICU patients. AbstractThe muscle wasting and impaired muscle function in critically ill intensive care unit (ICU) patients delay recovery from the primary disease, and have debilitating consequences that can persist for years after hospital discharge. It is likely that, in addition to pernicious effects of the primary disease, the basic life support procedures of long-term ICU treatment contribute directly to the progressive impairment of muscle function. This study aims at improving our understanding of the mechanisms underlying muscle wasting in ICU patients by using a unique experimental rat ICU model where animals are mechanically ventilated, sedated and pharmacologically paralysed for duration varying between 6 h and 14 days. Results show that the ICU intervention induces a phenotype resembling the severe muscle wasting and paralysis associated with the acute quadriplegic myopathy (AQM) observed in ICU patients, i.e. a preferential loss of myosin, transcriptional down-regulation of myosin synthesis, muscle atrophy and a dramatic decrease in muscle fibre force generation capacity. Detailed analyses of protein degradation pathways show that the ubiquitin proteasome pathway is highly involved in this process. A sequential change in localisation of muscle-specific RING finger proteins 1/2 (MuRF1/2) observed during the experimental period is suggested to play an instrumental role in both transcriptional regulation and protein degradation. We propose that, for those critically ill patients who develop AQM, complete mechanical silencing, due to pharmacological paralysis or sedation, is a critical factor underlying the preferential loss of the molecular motor protein myosin that leads to impaired muscle function or persisting paralysis.
Rechargeable sodium-sulfur (Na-S) batteries are regarded as a promising energy storage technology due to their high energy density and low cost. High-temperature sodium-sulfur (HT Na-S) batteries with molten sodium and...
Tremendous efforts are devoted to developing advanced electrode materials with superior electrochemical performance, high energy density, and high power density for energy storage and conversion. Two‐dimensional (2D) materials, owing to their unique properties, have shown great potential for energy storage. Following the discovery of graphene, a new family of 2D transition metal carbides/nitrides, MXenes, derived from MAX phase precursors, have attracted extensive attention in recent years. The superior physical and chemical properties of MXenes include high mechanical strength, excellent electrical conductivity, multiple possible surface terminations, hydrophilic features, superior specific surface area, and the ability to accommodate intercalants. When applied as electrodes in lithium‐based batteries, MXenes have demonstrated excellent performance. In this progress report, the authors summarize the recent advances of MXenes and MXene‐based composites in terms of synthesis strategies, morphology engineering, physical/chemical properties, and their applications in lithium‐ion batteries and lithium–sulfur batteries. Furthermore, challenges and perspectives for MXenes and MXene‐based composites for lithium‐based energy storage devices are also outlined.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.